10-93500232-G-A

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1

The NM_018131.5(CEP55):​c.181G>A​(p.Glu61Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000754 in 1,605,544 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000053 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000078 ( 1 hom. )

Consequence

CEP55
NM_018131.5 missense, splice_region

Scores

1
8
10
Splicing: ADA: 0.9374
1
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.38
Variant links:
Genes affected
CEP55 (HGNC:1161): (centrosomal protein 55) Enables identical protein binding activity. Involved in cranial skeletal system development; establishment of protein localization; and midbody abscission. Acts upstream of or within mitotic cytokinesis. Located in Flemming body; centriolar satellite; and plasma membrane. Implicated in multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0980722).
BP6
Variant 10-93500232-G-A is Benign according to our data. Variant chr10-93500232-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2589883.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000525 (8/152322) while in subpopulation SAS AF= 0.00166 (8/4830). AF 95% confidence interval is 0.000824. There are 1 homozygotes in gnomad4. There are 8 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP55NM_018131.5 linkc.181G>A p.Glu61Lys missense_variant, splice_region_variant Exon 2 of 9 ENST00000371485.8 NP_060601.4 Q53EZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP55ENST00000371485.8 linkc.181G>A p.Glu61Lys missense_variant, splice_region_variant Exon 2 of 9 1 NM_018131.5 ENSP00000360540.3 Q53EZ4-1

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152204
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000194
AC:
47
AN:
242488
Hom.:
0
AF XY:
0.000297
AC XY:
39
AN XY:
131414
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000778
AC:
113
AN:
1453222
Hom.:
1
Cov.:
29
AF XY:
0.000120
AC XY:
87
AN XY:
723224
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00129
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000666
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152322
Hom.:
1
Cov.:
32
AF XY:
0.000107
AC XY:
8
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00166
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151
ExAC
AF:
0.000173
AC:
21
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 17, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: CEP55 c.181G>A (p.Glu61Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00019 in 242488 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in CEP55 causing Multinucleated Neurons-Anhydramnios Dysplasia-Cerebellar Hypoplasia-Hydranencephaly Syndrome, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.181G>A in individuals affected with Multinucleated Neurons-Anhydramnios Dysplasia-Cerebellar Hypoplasia-Hydranencephaly Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2589883). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Inborn genetic diseases Benign:1
Aug 15, 2023
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.17
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.023
T
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.098
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Uncertain
2.4
M
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.15
Sift
Uncertain
0.0070
D
Sift4G
Uncertain
0.014
D
Polyphen
0.98
D
Vest4
0.72
MutPred
0.30
Gain of MoRF binding (P = 0.0039);
MVP
0.48
MPC
0.60
ClinPred
0.12
T
GERP RS
4.5
Varity_R
0.30
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.94
dbscSNV1_RF
Pathogenic
0.72
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs551482419; hg19: chr10-95259989; API